Ozari vs Hers: $39 to Start, $298 a Month to Stay

The Hers first month can cost as little as $188 — a $39 membership plus a $149 Wegovy® pill at its listed starting price. Month two is different. The membership auto-renews at $149, so the same pill now costs $298 all-in. That $110 jump between month one and month two is the single most useful fact in the Hers pricing model.

What Hers Publicly Lists

As of August 2026, forhers.com/weight-loss lists an all-branded lineup, mirroring its sibling brand Hims:

• Wegovy® Pill (including a microdosing plan): from $149/month
• Foundayo™ Pill and Ozempic® Pill: from $149/month
• Wegovy® Pen: from $199/month
• Ozempic®: from $199/month
• Zepbound® Vial and KwikPen®: from $299/month
• Retail Mounjaro® or Zepbound®: $1,899/month

Every listing states "Membership required." The Hers footnote is explicit: the price "includes medication only, if prescribed," the membership is "$39 for the first month, auto-renews at $149/month thereafter," is "billed separately," and "does not include or guarantee a prescription." Hers also discloses the program is "not available in all 50 states." The site carries a LegitScript seal.

Note the history: Ozari's true-cost tracker, verified May 2026, listed Hers compounded semaglutide at $199/month plus the $149 membership. The compounded option no longer appears on the Hers storefront — today's lineup is branded only. Verify current offerings directly with Hers.

How the Models Compare

Give Hers its due. Everything it now sells for weight loss is FDA-approved, the FDA badges are printed on the product cards, and the membership buys real services: a care team, in-app tracking, dosage-adjustment support, and nutrition guidance. For women who want a brand-name product and a polished app, the offer is coherent.

The structure is the issue for budget shoppers. Two charges, every month. The membership bills whether or not medication ships that month, and a prescription is never guaranteed by paying it. Ozari's model is one flat charge that already includes the provider review, the medication from a licensed 503A US compounding pharmacy, and shipping.

These are also different medications. Wegovy® and Zepbound® are FDA-approved; Ozari's compounded semaglutide and tirzepatide are not FDA-approved. Nobody should tell you they are interchangeable.

The 12-Month Math

Cheapest listed Hers route — the Wegovy® pill at its starting dose price:

• Medication: $149 × 12 = $1,788
• Membership: $39 + ($149 × 11) = $1,678
• Year-one total: $3,466

The pen route: $199 × 12 = $2,388 + $1,678 = $4,066. Zepbound® vial: $299 × 12 = $3,588 + $1,678 = $5,266. "From" pricing means higher doses can cost more, so treat these as floors.

Ozari's published year one:

• Semaglutide: $257 (starter) + $145 × 9 = $1,562
• Tirzepatide: $125 × 3 + $199 × 9 = $375 + $1,791 = $2,166

Against the cheapest Hers path, Ozari's semaglutide plan runs $1,904 less over twelve months. Against the Zepbound® vial path, the tirzepatide plan runs $3,100 less.

A note from Johanna Galyen, APRN, FNP: The riskiest week in any provider switch is the one with nothing in the fridge. We see patients who cancel first and start shopping second — then arrive at their new intake ten days past a missed dose. Sequence it the other way: complete the new provider's review, wait for a confirmed ship date, then cancel the old plan. If a gap stretches past two weeks mid-titration, expect your prescriber to step you down a level before resuming.

Key Comparison Table

Before you pay any provider, check it against the eight red flags that rule out a GLP-1 provider.

Hers is a legitimate, certified operator. The GLP-1 market also contains sellers who are not. Skip any provider that:

• Offers GLP-1s without a prescription or provider review
• Markets "generic Ozempic" — there is no US generic semaglutide
• Claims its compounded medications are FDA-approved
• Refuses to disclose its dispensing pharmacy
• Sells "research use only" vials for human use
• Promises guaranteed pounds lost

How to Cancel Hers

Hers cancellations run through the shared Hims & Hers help center, and the process is self-serve. Log in through the Hers app or forhers.com, open Account → Subscriptions, select the plan, and under "Manage subscription" pick "Stop auto-renew on my medication or membership." The help center's guidance, current as of 2026, adds two cautions worth taking literally. Act at least 48 hours before your next order date, because a cancellation cannot recall an order already in processing. And treat the medication plan and the $149/month membership as two separate switches — per the Hims & Hers support pages, ending the medication alone leaves the membership billing every month until you cancel it too. Refunds of already-billed charges are not part of the standard flow, so timing is the whole game. Before you close the tab, message support through the secure portal asking for written confirmation, and screenshot both the cancellation screen and the reply. Ozari's cancellation terms are published on its refund policy page: https://www.ozarihealth.com/refund-policy

Frequently Asked Questions

How much does Hers weight loss really cost per month?

After the first month, the floor is about $298: a from-$149 medication price plus the $149/month membership. Higher doses and injectable or Zepbound® options raise the medication portion. Verify current pricing directly with Hers.

Is the Hers membership optional?

No. Hers states medication is not available without an active Weight Loss Membership, which is billed separately and does not guarantee a prescription.

Does Hers still offer compounded semaglutide?

The August 2026 storefront lists only branded products. Ozari's tracker previously recorded a $199/month compounded semaglutide listing in May 2026. Confirm current options with Hers directly.

What would a year on Ozari cost instead?

$1,562 for the semaglutide starter-then-quarterly path ($257 starter, then $145 × 9), or $2,166 for tirzepatide ($125 × 3, then $199 × 9). No membership fee is added.

Are Hers and Ozari medications the same?

No. Hers dispenses FDA-approved branded drugs. Ozari offers compounded semaglutide and tirzepatide, which are not FDA-approved and are prepared by licensed 503A US compounding pharmacies after provider review.

Is Hers available everywhere?

Hers discloses its weight-loss program is not available in all 50 states. Ozari confirms availability state by state during intake, covering all 50 states.

How do I cancel Hers?

Log in via the Hers app or forhers.com, go to Account → Subscriptions, and select "Stop auto-renew on my medication or membership" under Manage subscription. Do it at least 48 hours before your next order date, and remember the membership cancels separately from the medication.

Is Hers legitimate?

Hers requires licensed provider review and discloses that compounded medications are not FDA-approved, per its published pages. Hers states it holds LegitScript certification; you can confirm that at legitscript.com and check its pharmacy licensure before ordering.

This article is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Always consult a licensed healthcare provider before starting any weight-loss medication. Ozari Health connects patients with licensed independent providers who determine whether treatment is appropriate.

Sources

• https://www.forhers.com/weight-loss
• https://www.forhers.com/weight-loss/membership
• https://www.ozarihealth.com/true-cost/hers
• https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
• https://www.ozarihealth.com/compounded-semaglutide
• https://www.ozarihealth.com/compounded-tirzepatide
• https://huggingface.co/datasets/Ozarihealth/glp1-telehealth-pricing-2026
• https://support.hims.com/hc/en-us/articles/48319574248603-How-do-I-cancel-my-weight-loss-membership
• https://support.hims.com/hc/en-us/articles/360000962263-How-do-I-cancel-my-subscription
• https://www.ozarihealth.com/refund-policy